Advanced UC
Showing 9976 - 10000 of >10,000
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, NSCLC Trial in Worldwide (Ramucirumab, MEDI4736)
Completed
- Gastric Cancer
- +3 more
-
Santa Monica, California
- +27 more
Jan 18, 2021
Microvascular Coronary Dysfunction Trial in Los Angeles (Handgrip, Altitude simulation, Leg exercise)
Recruiting
- Microvascular Coronary Dysfunction
- Handgrip
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Aug 17, 2021
Pediatric ALL, Transplant; Failure, Heart Trial in Edmonton (MedBIKE HIIT)
Recruiting
- Pediatric ALL
- Transplant; Failure, Heart
- MedBIKE HIIT
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jul 6, 2022
Multiple Myeloma Trial in United States (Lenalidomide, Daratumumab/rHuPH20)
Recruiting
- Multiple Myeloma
-
Anchorage, Alaska
- +698 more
Jan 24, 2023
Cystic Fibrosis, Sickle Cell Disease, SARS CoV 2 Infection Trial in Irvine (Exercise)
Recruiting
- Cystic Fibrosis
- +2 more
- Exercise
-
Irvine, CaliforniaUniversity of California, Irvine
Jan 5, 2023
Renal Cell Carcinoma Trial in Worldwide (TRC105 and Axitinib, Axitinib)
Terminated
- Renal Cell Carcinoma
- TRC105 and Axitinib
- Axitinib
-
Birmingham, Alabama
- +38 more
Oct 15, 2020
Ovarian Cancer Trial (Cytoreductive Surgery (CRS), Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Neoadjuvant Chemotherapy
Completed
- Ovarian Cancer
- Cytoreductive Surgery (CRS)
- +4 more
- (no location specified)
Mar 17, 2021
Locally Advanced Esophageal Squamous Cell Carcinoma Trial in Chengdu (Sintilimab, Chemotherapy, Radiation Therapy)
Unknown status
- Locally Advanced Esophageal Squamous Cell Carcinoma
- Sintilimab
- +2 more
-
Chengdu, Sichuan, ChinaSichuan Cancer Hospital & Institute
Oct 23, 2020
Efficacy, Toxicity, Drug Trial in Beijing (Apatinib Mesylate)
Completed
- Efficacy
- Toxicity, Drug
- Apatinib Mesylate
-
Beijing, Beijing, China
- +1 more
Jan 2, 2021
Colitis, Ulcerative, IBD, Colitis Trial in Toronto (Educational video)
Completed
- Colitis, Ulcerative
- +3 more
- Educational video
-
Toronto, Ontario, CanadaMount Sinai Hospital
Feb 26, 2020
Metabolism and Nutrition Disorder Trial in Jette (Nutrition Therapy, Control Therapy)
Completed
- Metabolism and Nutrition Disorder
- Nutrition Therapy
- Control Therapy
-
Jette, BelgiumUZ Brussel
Dec 8, 2021
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +4 more
- Biospecimen Collection
- +9 more
-
Birmingham, Alabama
- +848 more
Aug 24, 2022
Hepatocellular Carcinoma Trial in Wuhan (Jiu-wei-zhen-xiao Granule)
Completed
- Hepatocellular Carcinoma
- Jiu-wei-zhen-xiao Granule
-
Wuhan, Hubei, ChinaHubei Provincial Hospital of Traditional Chinese Medicine
Apr 7, 2021
Healthy Volunteers Trial in Cincinnati (Secretin)
Completed
- Healthy Volunteers
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 24, 2020
Recurrent/Advanced Gastric Cancer Trial in Seoul (Chemotherapy)
Not yet recruiting
- Recurrent/Advanced Gastric Cancer
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Aug 22, 2022
Gastrointestinal Stromal Tumors Trial in Beijing (Famitinib capsules, Sunitinib Capsules)
Recruiting
- Gastrointestinal Stromal Tumors
- Famitinib capsules
- Sunitinib Capsules
-
Beijing, China307 Hospital of PLA
Nov 30, 2020
NSCLC Stage IV, Oligometastasis Trial in Xi'an (Toripalimab in Combination With Platinum-based Chemotherapy, Surgical treatment
Recruiting
- NSCLC Stage IV
- Oligometastasis
- Toripalimab in Combination With Platinum-based Chemotherapy
- +2 more
-
Xi'an, Shaanxi, ChinaThe Fourth Military Medical University Tangdu Hospital
Sep 15, 2021
HIV, Pregnancy Trial in United States (rgp120/HIV-1MN)
Completed
- HIV Infections
- Pregnancy
- rgp120/HIV-1MN
-
San Francisco, California
- +5 more
Oct 28, 2021
Cutaneous T Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome Trial in Leeds ([14C]-resminostat)
Completed
- Cutaneous T Cell Lymphoma
- +2 more
-
Leeds, United KingdomCovance Clinical research Unit Ltd.
Feb 3, 2022
Anal Canal Squamous Cell Carcinoma Trial in Seoul (BI 754091, BI 836880)
Withdrawn
- Anal Canal Squamous Cell Carcinoma
- BI 754091
- BI 836880
-
Seoul, Korea, Republic ofAsan Medical Center
Nov 12, 2021